Renal Sympathetic Denervation for the Management of Chronic Hypertension (RELIEF)
Sponsor: Biosense Webster, Inc.
This NA trial investigates Uncontrolled Hypertension and is currently completed. Biosense Webster, Inc. leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biosense Webster, Inc.
- Vivek Reddy
For direct contact, visit the study record on ClinicalTrials.gov .